Work

Intellectual capital efficiency and operating performance in ASEAN pharmaceutical firms: the moderating role of R&D intensity

Year: 2026
Type: article
Abstract: This study examines whether R&D intensity moderates the relationship between intellectual capital efficiency and operating performance among publicly listed pharmaceutical firms in six ASEAN countries. The sample comprises 596 firm-year observations from 70 firms over the 2015–2024 period and is analysed using a two-way fixed-effects model. Intellectual capital efficiency is measured using the Value-Added Intellectual Coefficient (VAIC), operating performance by return on invested capital (ROIC) and R&D intensity by R&D expenditure relative to sales. The baseline results show a positive but statistically insignificant association between VAIC and ROIC. Contrary to the hypothesised positive moderation, the contemporaneous VAIC–R&D interaction is negative and statistically significant in the combined sample. The marginal effects remain positive at the three evaluated R&D levels, namely 0%, the sample mean and the 90th percentile, suggesting attenuation rather than reversal at these levels. Component-level analysis reveals heterogeneous patterns, with positive interactions for HCE and CEE but a negative interaction for SCE. Although the negative interaction is retained under several alternative specifications, the lagged interaction is not statistically significant, and excluding Singapore reverses the contemporaneous interaction to a positive coefficient. The contribution centres on a weakening contemporaneous VAIC–ROIC association whose generalisability is limited by sensitivity to predictor timing and country composition. Unresolved endogeneity further precludes interpreting this association as a causal mechanism.
Language: English
Open Access status: gold
Estimated APC paid: $1,165
OpenAlex ID: W7236736343
FWCI:
Cites: 35
Cited by:
Related to: 10